Labshake search
Citations for R&D Systems :
701 - 750 of 1395 citations for Cleaved PARP Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... 200 IU/ml of recombinant human IL-2 (R&D Systems, 202-IL-050) and expanded for 10 – 14 days ...
-
bioRxiv - Neuroscience 2022Quote: Pentraxins Binding C1q Purified recombinant neuronal pentraxin proteins (4 µg/mL, R&D Systems) or IgM (2 µg/mL ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (R&D Systems, Minneapolis, MN), recombinant human interleukin 4 (IL-4 ...
-
bioRxiv - Developmental Biology 2023Quote: The following recombinant proteins and small molecules were used: BMP4 (R&D Systems; 314BP050), Noggin (250ng/ml ...
-
bioRxiv - Developmental Biology 2023Quote: The following recombinant proteins and small molecules were used: BMP4 (R&D Systems; 314BP050), Noggin (500ng/ml ...
-
bioRxiv - Microbiology 2023Quote: ... Recombinant human Wnt-3a (rhWnt-3a) (#5036-WN, R&D Systems; Minneapolis, Minnesota, USA) was resuspended according to manufacturer’s instructions and stored at −80°C.
-
bioRxiv - Genetics 2023Quote: ... and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
ANGPTL8 R59W variant influences inflammation through modulating NF-κB pathway under TNFα stimulationbioRxiv - Biochemistry 2023Quote: ... the cells were treated with Recombinant Human TNFα Protein (R&D Systems, MN, USA) at 25ng/mL for 18 hours ...
-
bioRxiv - Immunology 2023Quote: ... BMDMs were treated with recombinant mouse SPARCL1 (5-20 μg/ml, R&D system, #4547-SL ...
-
bioRxiv - Biophysics 2023Quote: ... and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ, R&D Systems) (Farnsworth et al. ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL− 1 BMP-4 (human recombinant) (R&D Systems, Minneapolis, MN, USA), 10 µM LY294002 (Cayman Chemical ...
-
bioRxiv - Cell Biology 2023Quote: ... or with the addition of 5µg/mL recombinant Periostin (R&D Systems, #2955-F2) overnight at 4°C ...
-
bioRxiv - Biochemistry 2023Quote: ... we used commercial recombinant human OGT fragment (Cys323-Glu1041) (R&D systems, 8446-GT). Thereafter ...
-
bioRxiv - Cancer Biology 2023Quote: ... 200ng/mL recombinant Human Wnt3a (R&D System, Cat. No. 5036-WN-010/CF) or Wnt5a (R&D System ...
-
bioRxiv - Immunology 2023Quote: ... and 1 ng/ml recombinant human basic fibroblast growth factor (bFGF)(R&D Systems). Human MSCs were obtained from ATCC (catalog #PCS-500-012 ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 20 ng/mL of recombinant mouse interleukin (IL)- 2 (R&D systems), 8% CTS Immune Cell Serum Replacement (Thermo Fisher) ...
-
bioRxiv - Cell Biology 2023Quote: ... or with the addition of 5ug/mL recombinant Periostin (R&D Systems, #2955-F2). After 24h incubation ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Bioengineering 2023Quote: ... 1.5 mL CDM with 6 ng/mL human recombinant activin A (R&D Systems) and 5 ng/mL bFGF (R&D Systems ...
-
bioRxiv - Cell Biology 2024Quote: ... cells were stimulated with 100 ng/mL recombinant WNT3A (R&D Systems, 5036-WN) or WNT5A (R&D Systems ...
-
bioRxiv - Microbiology 2024Quote: ... In devices pre-treated with recombinant Ang-1 (923-AB-025, R&D Systems), pre-incubation occurred at 18-hours ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Biochemistry 2023Quote: Recombinant human angiogenin (catalog number 265-AN/CF) was purchased from R&D Systems, a Bio-Techne Company (Minneapolis ...
-
bioRxiv - Cell Biology 2024Quote: ... and recombinant human or murine Fc-ICAM-1 (10 μg/ml) (R&D Systems) coated plates ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 20 ng/mL of recombinant human oncostatin M (OSM, R&D systems). For the co-culture experiment ...
-
bioRxiv - Molecular Biology 2023Quote: ... with or without 1 ng/mL recombinant human BMP9 (R&D Systems, Minneapolis, MN) for an additional 24 hours ...
-
bioRxiv - Cell Biology 2024Quote: Human colonic organoids were treated with recombinant human IL-22 protein (R&D Systems) at 10 ng/mL ...
-
bioRxiv - Molecular Biology 2024Quote: ... and incubated in media containing recombinant 50ng/mL hEGF (R&D Systems Minneapolis, MN), 100ng/mL hNoggin (Shenandoah Warminster ...
-
bioRxiv - Neuroscience 2024Quote: ... recombinant full length membrane-bound Fractalkine (R&D systems, cat. #472-FF, Accession # O35188) is sf21 (baculoviris)-derived mouse CX3CL1/Fractalkine protein of 34 kDa and 312 amino acids and recombinant soluble Fractalkine (R&D systems ...
-
bioRxiv - Bioengineering 2024Quote: ... The assay was run according to manufactures protocol with recombinant LOXL2 (R&D Systems) used as a positive control and results normalized to sample DNA determined via the Quant-iT Picogreen dsDNA assay.
-
bioRxiv - Biochemistry 2024Quote: Human recombinant CatA was first activated by following the manufacturer’s instructions (R&D Systems), incubating at 37°C 10 µg/mL CatA with 1 µg/mL CatL in an activation buffer (25 mM MES pH = 6.0 ...
-
bioRxiv - Bioengineering 2024Quote: ... along with 50 ng/ml recombinant human GDNF (R&D Systems, 212-GD-010) were administered for 12 hr ...
-
bioRxiv - Biophysics 2023Quote: A recombinant P-selectin-Fc fusion protein (R&D Systems # 137-PS; ∼300 kDa) was purchased from Bio-Techne (Abingdon ...
-
bioRxiv - Bioengineering 2021Quote: ... Virus infection was detected with mouse mAb to SARS-CoV- 2 nucleocapsid (N) (R&D Systems, Minneapolis, MN, Cat#MAB10474) and counterstained with rabbit anti-mouse IgG-HRP (Rockland Immunochemicals ...
-
bioRxiv - Immunology 2022Quote: ... The solubilized hDectin-1 was captured on beads with an anti-hDectin-1 mAb (MAB1859, R&D Systems, Minneapolis, MN). For glycosidase analysis ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant mouse ICAM-1-Fc and VCAM-1-Fc were purchased from R&D Systems. Antibodies for flow cytometery were from BioLegend ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant rat fractalkine (200 ng/ml; R&D Systems, MN, USA, #537-FT-025/CF) or vehicle (PBS ...
-
bioRxiv - Immunology 2021Quote: ... in the absence or presence of 10nM soluble recombinant TM (R&D Systems/Biotechne, USA). Activation of PC (6.25-800nM ...
-
bioRxiv - Developmental Biology 2019Quote: ... 0.01% of recombinant human FGF basic protein 10μg/ml (R&D Systems, #233-FB-025).
-
bioRxiv - Genomics 2020Quote: ... 20 mM HEPES) supplemented with 60 ng/mL recombinant mouse M-CSF (R&D systems). For analysis of proliferation ...
-
bioRxiv - Bioengineering 2021Quote: Recombinant human IDO expressed in Escherichia coli was purchased from R&D Systems (Minneapolis, MN) with a predicted molecular mass of 46 kDa a specific activity of >500pmoles/min/μg (or for equimolar calculations >29 pmol NFK/min/pmol IDO ...
-
bioRxiv - Physiology 2020Quote: ... Cells were stimulated with 50 ng/mL recombinant rat EGF (R&D systems, Minneapolis, MN) for times indicated.
-
bioRxiv - Cancer Biology 2020Quote: ... 10 ng/ml IL6 + 0.1 ng/ml recombinant human sgp130-Fc (R&D Systems, Germany) or 20 ng/ml Hyper-IL6 (kind gift of S ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/ml murine recombinant fibroblast growth factor 8b (FGF-8b, R&D Systems) for 7 days in vitro (DIV) ...
-
bioRxiv - Microbiology 2020Quote: ... infected HFF monolayers were stimulated with 100U/mL recombinant human IFN-γ (R&D Systems) 24 hours post-infection and fixed 6 hours post-stimulation ...
-
bioRxiv - Systems Biology 2020Quote: ... Recombinant BMP ligands were acquired from R&D Systems (BMP4, #5020-BP; BMP9, #5566-BP).
-
bioRxiv - Cancer Biology 2020Quote: ... CMK lines were treated with 200 ng/ml of recombinant human WNT3A (R&D systems) for 4 hours ...